These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1659789)

  • 1. [Enoxaparin in the prevention of deep venous thrombosis in general surgery].
    Eddi A
    Agressologie; 1991; 32(4):230-2. PubMed ID: 1659789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
    Samama M; Combe S
    Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of postoperative thrombosis with low-molecular-weight heparins].
    Jørgensen LN; Wille-Jørgensen PA; Hauch O
    Ugeskr Laeger; 1994 Sep; 156(39):5667-72. PubMed ID: 7985248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
    Colwell CW; Spiro TE
    Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S
    Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of thrombosis with unfractionated and low molecular weight heparin].
    Breddin HK
    Wien Med Wochenschr; 1989 Dec; 139(23):555-9. PubMed ID: 2560285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11).
    Moreno Gonzalez E; Fontcuberta J; de la Llama F
    Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enoxaparin in the prevention of deep venous thrombosis.
    Ament PW; Bertolino JG
    Am Fam Physician; 1994 Dec; 50(8):1763-8. PubMed ID: 7977005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery].
    Grunebaum L; Fricker JP; Wiesel ML; Vergnes Y; Kapps J; Cazenave JP
    J Mal Vasc; 1987; 12 Suppl B():102-4. PubMed ID: 2834478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
    Labas P; Ohrádka B; Vladimír J; Cambal M
    Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery.
    Breddin HK
    Semin Thromb Hemost; 1999; 25 Suppl 3():83-9. PubMed ID: 10549721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations.
    Borris LC; Lassen MR; Jensen HP; Andersen BS; Poulsen KA
    Int J Clin Pharmacol Ther; 1994 May; 32(5):262-8. PubMed ID: 7921522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enoxaparin prophylaxis in elective hip surgery.
    Turpie AG
    Acta Chir Scand Suppl; 1990; 556():103-7. PubMed ID: 1963014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of deep vein thrombosis by enoxaparin after total hip prosthesis].
    Vochelle N; Planes A
    Agressologie; 1990 Mar; 31(3):145-8. PubMed ID: 2173435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antithrombotic efficacy and haemorrhagic side-effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery.
    Planes A
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S33-5; discussion S37-8. PubMed ID: 8180327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
    Haas S; Flosbach CW
    Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.